Company presentation Stockholm Corporate Finance AB Birger - - PowerPoint PPT Presentation

company presentation
SMART_READER_LITE
LIVE PREVIEW

Company presentation Stockholm Corporate Finance AB Birger - - PowerPoint PPT Presentation

Company presentation Stockholm Corporate Finance AB Birger Jarlsgatan 32A, 114 29 Stockholm, Visiting address: Engelbrektsplan 1, Tel +46 8 440 56 40 Fax +46 8 440 56 41. www.stockholmcorp.se STOCKHOLM CORPORATE FINANCE About Stockholm


slide-1
SLIDE 1

Birger Jarlsgatan 32A, 114 29 Stockholm, Visiting address: Engelbrektsplan 1, Tel +46 8 440 56 40 Fax +46 8 440 56 41. www.stockholmcorp.se

Company presentation

Stockholm Corporate Finance AB

slide-2
SLIDE 2

Stockholm Corporate Finance

Stockholm Corporate Finance AB

  • Stockholm Corporate Finance is a Swedish, independent and privately
  • wned corporate finance adviser.
  • Stockholm Corporate Finance is under supervision of the Swedish Financial

Supervisory Authority (Swe. Finansinspektionen).

  • Stockholm Corporate Finance is the Swedish partner in the global network

M&A Worldwide.

  • The company has 17 qualified professionals working from our office in

Stockholm.

  • Stockholm Corporate Finance has completed more than 180 transactions

since its inception 2005.

  • Our professionals have extensive experience in corporate finance and

several of us have held senior executive positions in several listed firms.

  • Stockholm Corporate Finance offers financial advisory by taking

transaction initiatives, acting in an advisory capacity and assisting with the transaction process implementation by working closely with owners, board members and management in listed companies as well as privately held companies.

  • Stockholm Corporate Finance has a broad and well-established network

and thereby ample placing power.

STOCKHOLM CORPORATE FINANCE

2

About Stockholm Corporate Finance Two main areas of business

Capital raising

➢ Directed Share Programs ➢ Rights issues ➢ Initial Public Offerings and public listings ➢ Underwriting arrangements ➢ Private Placements ➢ Secondary Offerings ➢ Market quotations

M&A-transactions

➢ Mergers ➢ Acquisitions ➢ Divestitures ➢ Leveraged Buyouts, Management Buyouts, Public Buyouts ➢ Restructuring & Reconstructions ➢ Strategic Advisory ➢ Company Valuations ➢ Fairness Opinions

slide-3
SLIDE 3

Stockholm Corporate Finance Algeria Emergence North Africa Partners Argentina Finanzas & Gestión Australia Johnsons Corporate Pty Ltd. Austria ACTIVE M&A Experts GmbH Belgium Omnicap Brazil Cypress Associates do Brasil Bulgaria Innimmo Advisers Ltd Canada Robbinex Inc. Czech Republic SauterRentsch China Morgen Evan Advisory Services Ltd. Croatia Denves Consulting Egypt FinCorp Investment Holding Finland Armatori Corporate Finance France (1) Linkers Fusions & Acquisitions; (2) MBA Capital Germany (1) ACTIVE M&A Experts GmbH; (2) S & P Mergers and Acquisitions Hong Kong SCS Global Consulting (Hong Kong) Limited Hungary International Mergers & Acquisitions India Corporate Catalyst India Pvt. Ltd. Israel MnA Team Italy (1) Avvalor Corporate Solutions Srl; (2) Bridge Kennedy International Srl Japan SCS Global Consulting KK Luxembourg T & T Merger & Acquisition Transactions Malaysia SCS Global Advisory (M) S/B Mexico Corporate Finance Services Mexico Morocco Actipar Sarl Netherlands (1) Aeternus Corporate Finance; (2) T & T Merger & Acquisition Transactions Norway DHT Corporate Services AS Poland JP Weber Sp. z o.o. Portugal Fingeste Business Development Romania FRD Center Saudi Arabia AMWAL FINANCIAL CONSULTANTS Singapore SCS Global Holdings Pte Ltd South Africa IBN Business Solutions Spain ARS Corporate Finance Advisors SL Sweden Stockholm Corporate Finance AB Switzerland Adbodmer capital Thailand PYI Capital Company Ltd. Tunisia Emergence North Africa Partners Turkey Crossborder Corporate Consultancy Ukraine America 2030 LLC United Kingdom (1) Bluebox Corporate Finance; (2) Rickitt Mitchell & Partners Limited USA Focus LLC; Morgen Evan Advisory Services Ltd. Vietnam PYI Capital Company Ltd.

M&A WORLDWIDE

3

Exclusive Swedish partner of M&A Worldwide.

The Network for Mergers & Acquisitions

  • M&A Worldwide is a leading global network of merger & acquisition

specialists, comprised of 43 investment banks, boutiques, and firms in 45 countries.

  • M&A Worldwide’s purpose is to initiate and complete cross-border

transactions such as mergers, acquisitions, divestitures, joint-ventures, and

  • ther strategic transactions.
  • Through its partnerships, M&A Worldwide has access to strategic buyers,

M&A-candidates and financial partners in order to ensure the best possible

  • utcome in every transaction.
  • Stockholm Corporate Finance is the exclusive Swedish partner of M&A

Worldwide.

A global network

slide-4
SLIDE 4

Stockholm Corporate Finance

Co-workers

Employees

STOCKHOLM CORPORATE FINANCE – TEAM

Otto Rydbeck (born 1979) CEO and Partner

MSc in Industrial Management and Engineering from the Faculty of Engineering at Lund University. Experience from capital raising, M&A and company valuations within e.g. life science, IT, the engineering industry and

  • shipping. Board member of e.g. Prudentus Capital Oy.

Axel Enström (born 1984) Executive Vice President and Partner

MSc from School of Economics in Lund. Experienced in ECM, mainly capital raisings to listed companies but also in the private sector, Further experience in DCM, M&A and valuation. Employed by Stockholm Corporate Finance since in 2010.

Daniel Hofmann (born 1976) Senior Adviser and Partner

MBA from the Stockholm School of Economics and BA from Stockholm University. Previously active at Swedbank Corporate Finance and Hagströmer & Qviberg Corporate Finance and Corpbox. Daniel is a partner and board member of a number of small unlisted companies.

Markus Lagerlöf (born 1974) VP Life Science

MSc in Industrial Engineering and Management from Linköpings Tekniska Högskola. Previous experience from Pharma and Life Science at Pfizer, Novartis, GSK, GE Healthcare and Sandoz within sales, marketing, strategy, business development and general management. Global, regional – including Central and Eastern Europe/Russia – and local responsibilities based out of New York, London, Munich and Stockholm.

Magnus Härning-Nilsson (born 1957) Senior Partner

MSc in Economics from Lund University. Previously positions with Nordea, Gota Bank, Aragon, EPO.com and as a Senior Partner at Momentor AB. Board member of Ellen AB and Tarantech AB and member of Advisory Board for Sreg.AB.

Daniel Hummel (born 1971) Senior Adviser

MSc in Business Administration from Stockholm University. Daniel has held a large number of senior positions in the capital market, including Head of Swedbank Corporate Finance and COO for Swedbank Markets. Daniel has also been the CEO of the listed investment company, AB Fastator.

Gunnar Wedfelt (born 1952) Senior Partner and co-founder

MSc in Business Administration from Stockholm University. Sparbankernas Bank Securities Department (head of securities department), Stockholm Fondkommission (partner and board member), ESWÖ Partners FK (partner and founder), Servisen FK, Nordiska FK. Gunnar has worked with both institutional and corporate clients in his various positions, most recently as Head of Corporate Finance at Nordiska Fondkommission. Gunnar has run his own venture capital and investment business.

Harry Nudel (born 1960) Senior Partner and co-founder

MSc in Business Administration from Lund University. Has previously held positions at Stockholm Fondkommission and listed companies such as Balken Invest, Gotic, Wilh. Sonesson and Active Capital. Positions included institutional broker, portfolio manager, CFO, business developer and head

  • f investor Relations.
slide-5
SLIDE 5

Stockholm Corporate Finance

Co-workers

Employees

STOCKHOLM CORPORATE FINANCE – TEAM

Per Thunander (born 1952) Senior Adviser

Studied at Handelshögskolan in Stockholm. Active in the stock- and venture capital markets since 1972, at Öhman Fk, Affärsvärlden, Investment AB Beijer, ABB, Aros Fk, and Servisen.

Ingemar Lagerlöf (born 1949) Senior Adviser

MBA, has extensive experience and a broad network within the Swedish Life Science industry. Ingemar Lagerlöf has held several senior positions in life science companies as Product Manager at Sandoz (Novartis), Area Manager at Kabi Vitrum, General Manager at Kabi Pharmaceuticals, Managing Director of Fisons Pharmaceuticals Sweden, Nordic Manager at Fisons Pharmaceuticals, CEO of MiniDoc and most recently as CEO of LinkMedAB (publ).

Marcus Bonsib (Born 1986) Senior Associate

Bachelor's degree from Lund University School of Economics and Master's degree in Finance from Stockholm University. Previously worked as Investment Manager at Pepins Group AB and from own consultancy firm. Experience in raising capital, IPOs and Investor Relations.

Martin Wedfelt (born 1980) Senior Equity Sales Associate

MSc in Business Administration from Stockholm University School Of Business. Experience in capital raisings, IPO’s and Investors Relations. Employed by Stockholm Corporate Finance since 2013.

Marcus Rohdin (born 1985) Senior Associate

MSc in Business Administration from Lund University. Experience in structured products from Brownstein, Hyatt, Farber & Schreck, Washington D.C and EWN Opinio Juris AB. Employed by Stockholm Corporate Finance since 2014.

Albert Sandwall (Born 1990) Associate

Master's degree from the University

  • f

Edinburgh Business School specialising in Financial Management. Previous experience of Venture Capital investments in tech and of telecom investments in developing countries from the Kinnevik sphere. Employed at Stockholm Corporate Finance since 2019.

Linda Nottemark (born 1990) Associate

MSc in Business Administration from Stockholm Business School. Previous experience from trading surveillance at Nasdaq. Employed at Stockholm Corporate Finance since 2018.

Niklas de Mander (born 1980) Senior Associate

MSc in engineering from KTH, Masters programme in economics from Stockholm University School of business. Previous transaction based experience from positions at Mangold Fondkommission and Aqurat FK AB. Employed at Stockholm Corporate Finance since 2016.

slide-6
SLIDE 6

Stockholm Corporate Finance

6

STOCKHOLM CORPORATE FINANCE – TEAM

Peter Enström (born 1944) Chairman of the Board

Education in finance and law in Sweden and USA. CEO of several listed companies over the course of 13 years. Founder of TurnIT. Member of corporate management in around 10 listed companies. Board member in Nordbanken, Nordbanken Finans and Nordbanken Fonder for 7 years.

Ulf Risberg (born 1943) Member of the Board

Previously Board Member of e.g. Alfred Berg FK, B&B FK and Intentia. Former CEO of e.g. STC Finans and AB Probo (subsidiaries to Bilia AB).Member of the Board in Paynova and a number of privately owned companies.

Peter Ström (born 1952) Member of the Board

Has extensive experience from leading international positions within the Life Science-sector; KabiVitrum, KabiPharmacia, PharmaciaUpjohn and ImsHealth Inc. Other board appointments include Comtax, Vicore Pharma AB (publ), Dentosystem and WNT Research AB (publ).

Marie Reinius (born 1961) Member of the Board

Msc in Business Administration. Former CEO of the Swedish Private Equity & Venture Capital Association. Extensive experience as CFO. Has held various board positions in both listed and non-listed companies the past 20

  • years. Member of the board in Swedbank, Sjuhärad and various risk capital

funds managed by Obligo Investment Management (Norway).

*The board of directors also consists of Senior Partner Harry Nudel

Employees The Board of Directors*

Andor Gerendas (born 1961) Senior Adviser

MSc and MBA. Andor has extensive experience of corporate finance and the swedish financial markets, in which he has held senior positions. His previous positions at Sandvik Coromant, Arthur D. Little, SEB Enskilda Securities, Bredbandsbolaget. He also served as Head

  • f

Nordea Corporate Finance Sweden, President Vinovo AB (publ) and CEO of Remium.

Jan Lundberg (born 1946) Senior Adviser

MSc from KTH. Previously active within Salén & Wicander Group 1972-1985. Own business and owner of Rekonstructa AB. Board member in several private companies.

slide-7
SLIDE 7

Stockholm Corporate Finance

PREVIOUS DEALS

7

Tombstones - 2020

QuiaPEG Rights issue 37,6 MSEK Life Science July 2020 Mälö Fastigheter Divestment Undisclosed Real Estate Q1 2020 Dynamic Code Directed share issue & Rights issue 60 MSEK Life Science March 2020 Sotkamo Silver Rights issue 62 MSEK Raw Materials May 2020 Lohilo Directed share issue & Secondary Placement Undisclosed Consumer Products May 2020 Cell Impact Warrants 38,4 MSEK Cleantech June 2020 Respiratorius Rights issue 48,5 MSEK Life Science June 2020 Sprint Bioscience Rights issue 25,1 MSEK Life Science June 2020 iZafe Sell-side mandate 40 MSEK Life Science July 2020 Dynamic Code Block Trade 49 MSEK Life Science July 2020

slide-8
SLIDE 8

Stockholm Corporate Finance

PREVIOUS DEALS

8

Tombstones - 2019

Lipum Private Placement 25 msek Life Science April 2019 iZafe Unitemission 20,1 MSEK Life Science December 2019 Single Technologies Directed Convertible loan 15 MSEK Life Science December 2019 Calmark Right unit issue of shares and warrants 24,3 MSEK Life Science December 2019 AdCityMedia Fairness opinion Media & Communication November 2019 Alvestaglass Private Placement 10 MSEK Consumer Products November 2019 Ibeco Sale of company to Norvatek Invest Industrial November 2019 Dala Kommunalteknik Sale of company to Norvatek Invest Industrial November 2019 Simris Alg Directed share issue & Rights issue 28,2 MSEK Life Science October 2019 Undisclosed Block trade 140 MSEK Real Estate October 2019 CarpoNovum Private Placement 30 MSEK Life Science September 2019 Dignitana Directed share issue

  • f units

42 MSEK Life Science September 2019 NextCell Pharma Rights issue 24,9 MSEK Life Science June 2019 Briox Directed share issue & Rights issue 36 MSEK Technology June 2019 Cell impact Directed share issue & Rights issue 78 MSEK Clean Tech Maj 2019 Vibrosense Rights issue 18 MSEK Life Science Maj 2019 Sotkamo Silver Directed share issue & Convertible loan 29 MSEK Raw Materials May 2019 Neurovive Directed share issue 28 MSEK Life Science March 2019 Neurovive Rights issue 99 MSEK Life Science February 2019 Minesto Warrants 44,4 MSEK Energy February 2019 Mabon Public cash offer 297 MSEK Financial Services January 2019 Mytaste Group Warrants 3,5 MSEK Technology January 2019 Copperstone Acquisition of Avalon Minerals Viscaria Raw Materials March 2019 Encare Private Placement 15 MSEK Life Science September 2019

slide-9
SLIDE 9

Stockholm Corporate Finance

PREVIOUS DEALS

9

Tombstones - 2018

Ecoclime Rights Issue 51,2 MSEK Clean Tech December 2018 Dynamic Code Private Placement 10 MSEK Life Science November 2018 Kopy Goldfields Rights Issue 25,2 MSEK Raw materials November 2018 Tradedoubler Fairness opinion Technology November 2018 Confidential Blocktrade 92,4 MSEK Real Estate October 2018 Nordic Iron Ore IPO Raw materials September 2018 Vironova Private Placement 115 MSEK Life Science September 2018 Combigene Rights issue 31 MSEK Life Science September 2018 Insplanet Fairness opinion Financial Services August 2018 Sleeping World Private Placement 21,5 MSEK Consumer Products August 2018 Nordic Iron Ore Rights Issue 36,5 MSEK Raw materials June 2018 Briox Warrants 22 MSEK Technology June 2018 Pharmiva Private placement Undisclosed Life Science April 2018 NeuroVive Rights isse 78,5 MSEK Life Science April 2018 Minesto Rights issue 73,5 MSEK Clean Tech February 2018 Confidential Blocktrade 100 MSEK Real estate August 2018

slide-10
SLIDE 10

Stockholm Corporate Finance

PREVIOUS DEALS

10

Tombstones - 2017

Impact Coatings Rights issue SEK 84m Technology December 2017 Impact Coatings Directed share issue SEK 25m Technology November 2017 MyTaste Rights issue SEK 18m Technology October 2017 Follicum Rights issue SEK 23.5m Life Science October 2017 Injecto Private Placement Undisclosed Life Science October 2017 Sotkamo Warrants SEK 53.2m Raw Materials September 2017 Assistansbolaget Block Trade Undisclosed Financial Services July 2017 WntResearch Rights issue SEK 64m Life Science October 2017 Klarabo Private Placement SEK 65m Real Estate June 2017 Maha Rights issue SEK 91.7m Energy June 2017 Bioservo IPO SEK 64.4m Technology May 2017 Briox Rights issue SEK 23m Technology April 2017 SealFX Private Placement Undisclosed Technology April 2017 Maha Directed share issue SEK 91.7m Energy February 2017 IRLAB IPO SEK 116m Life Science February 2017

slide-11
SLIDE 11

Stockholm Corporate Finance

PREVIOUS DEALS

11

Tombstones - 2016

Beowulf Directed share issue SEK 12.3m Raw materials December 2016 Oasmia Directed share issue SEK 70m Life Science October 2016 Kopy Goldfields Rights issue SEK 20m Raw Materials October 2016 InDex IPO SEK 250m Life Science September 2016 Gumbler Private Placement SEK 45m Technology September 2016 Briox Directed share issue SEK 5.5m Technology July 2016 Sotkamo Rights issue SEK 186m Raw Materials July 2016 Oasmia M&A SEK 25m Life Science October 2016 GomSpace Directed share issue SEK 25m Technology June 2016 Maha IPO SEK 118m Energy June 2016 Dignitana Rights issue SEK 19.4m Life Science June 2016 Oasmia Directed share issue SEK 42m Life Science June 2016 GomSpace IPO SEK 100m Technology June 2016 Dignitana Directed share issue SEK 33.1m Life Science May 2016 Redwood Pharma IPO SEK 15.8m Life Science May 2016 Mantex Private Placement SEK 14m Industrial May 2016 NeuroVive Rights issue SEK 94.4m Life Science May 2016 Aptahem Rights issue SEK 19.5m Life Science May 2016 WntResearch Rights issue SEK 22.5m Life Science May 2016 Litium IPO SEK 24m Technology April 2016 Oasmia Directed share issue SEK 45.5m Life Science April 2016 Deflamo Rights issue SEK 20m Industrial March 2016 Briox Rights issue SEK 21.1m Technology February 2016

slide-12
SLIDE 12

Stockholm Corporate Finance

PREVIOUS DEALS

12

Tombstones - 2015

CybAero Directed Share issue SEK 22.4m Technology December 2015 Akredo Private Placement SEK 5.5m Financial Services November 2015 SensoDetect Preferential rights Issue SEK 7.7m Life Science October 2015 Petrogrand Fairness Opinion Raw Materials October 2015 CybAero Rights Issue SEK 75m Technology September 2015 Litium Private Placement SEK 28m Technology September 2015 Gumbler Private Placement SEK 10m Technology July 2015 Wäsö Fastigheter Private Placement SEK 250m Real Estate June 2015 Brighter AB Preferential Rights Issue SEK 16.3m Life Science April 2015 Plotagon Private Placement SEK 23m Technology March 2015

slide-13
SLIDE 13

Stockholm Corporate Finance

PREVIOUS DEALS

13

Tombstones - 2014 & 2013

Maha Private Placement SEK 65m Energy May 2014 FINT AB Rights issue SEK 22.5m Technology December 2014 TeamSportia M&A Consumer Products December 2014 Maha Directed share issue SEK 100m Energy November 2014 Oniva Online Group Rights issue SEK 34m Technology September 2014 Ellen AB Rights issue SEK 5m Life Science September 2014 Isofol Medical Directed share issue SEK 45m Life Science August 2014 Oniva Online Group Directed share issue SEK 24m Technology July 2014 Mälö Fastigheter Private Placement SEK 250m Real Estate July 2014 Sotkamo Rights issue SEK 39m Raw Materials April 2014 Motion Display IPO SEK 20.8m Consumer Products April 2014 Oniva Online Group Rights issue SEK 65.4m Technology November 2013 Oniva Online Group Directed share issue SEK 20m Technology November 2013 FINT AB Directed share issue SEK 26m Technology November 2013 Image Systems Rights issue SEK 56.5m Technology Augusti 2013 Ellen AB Rights issue SEK 4.7m Life Science July 2013 Cryptzone AB Rights issue SEK 33.9m Technology June 2013 FINT (Fortnox International) Rights issue SEK 24m Technology June 2013 HittaHem.se Share issue Technology May 2013 Victoria Park Blocktrade Real Estate May 2013 Confidential Convertible loan Life Science March 2013

slide-14
SLIDE 14

Stockholm Corporate Finance

PREVIOUS DEALS

14

Tombstones - 2012 & 2011

Ellen AB Rights issue Biotech June 2012 Fortnox International IPO IT August 2011 Image Systems Rights issue IT/Software March 2012 Avonova Public Bid Health Care October 2012 Doxa AB Directed convertible bond issue Life Science October 2012 Sotkamo Silver Secondary listing Raw Materials June 2012 Sotkamo Silver Directed & Rights issue Raw Materials June 2012 Victoria Park Blocktrade Real Estate May 2012 Image Systems M&A IT/Software March 2012 Beowulf Mining PLC Directed share issue Raw materials November 2011 Kilsta Metallvärden Rights issue Industrial October 2011 Doxa Rights issue Life Science June 2011 Caplease Structured sales process Finance June 2011 Sotkamo Silver Secondary placement Raw materials April 2011 Precomp Solutions Structured sales process Industrial April 2011 Digital Vision Rights issue IT/Software April 2011 Digital Vision M&A IT/Software April 2011 Sotkamo Silver Warrant Raw materials March 2011 Seanet Rights issue Telecom February 2011

slide-15
SLIDE 15

Stockholm Corporate Finance

PREVIOUS DEALS

15

Tombstones - 2010 & 2009

Ellen Rights issue Biotech February 2010 Sotkamo Silver Directed share issue Raw materials December 2010 Glycorex Secondary placement Life Science February 2010 Axlon Rights issue IT December 2010 Accastum Partners M&A Finance June 2010 Diabetes Tools Rights issue Life Science June 2010 Mobispine Rights issue Telecom April 2010 Confidential Convertible Loan Life Science March 2010 Silver Resources OY M&A Raw materials March 2010 Silver Resources OY Private Placement Raw materials March 2010 Seanet Rights issue Telecom December 2009 Oasmia Directed share issue Life Science November 2009 Oasmia Secondary placement Life Science September 2009 Seanet Rights issue Telecom June 2009 Rothmans Sailing/ Tradewinds AB Private placement Business events May 2009 Ellen AB Rights issue Biotech February 2009 Consilium Directed share issue Industry February 2009 Confidential Financial consulting Renewable energy January 2009 Paynova Rights issue Financial services March 2009

slide-16
SLIDE 16

Stockholm Corporate Finance

PREVIOUS DEALS

16

Tombstones - 2008 & 2007

Seanet IPO First North Telecom June 2007 Drillcon Secondary placement Raw materials November 2008 Biomain M&A Medtech September 2008 Precomp Solutions Rights issue Industrial July 2008 Confidential Valuation Services June 2008 Kamera Content Divestment Media May 2008 Diamyd Medical Directed share issue Life Science April 2008 SRAB Kemtank 3 Private placement Transport February 2008 SRAB Shipping Directed share issue Transport January 2008 Confidential Valuation Industrial November 2007 Annehem Secondary placement Real estate October 2007 SRAB Kemtank 2 Private placement Transport September 2007 Studentum Private placement Services July 2007 Drillcon Secondary placement Raw materials July 2007 Consilium Directed share issue Industry June 2007 addNode Secondary placement IT June 2007 PSI Spelinvest IPO Online gaming June 2007 Annehem Listing Real estate May 2007 InWarehouse Fairness opinion Retail March 2007 Drillcon Directed share issue Raw materials March 2007 Kamera Content Private placement Media February 2007 Stille Secondary placement Med-tech January 2007 Confidential Fairness opinion Industrial June 2007 Victoria Park IPO First North Real estate November 2007

slide-17
SLIDE 17

Stockholm Corporate Finance

PREVIOUS DEALS

17

Tombstones - 2006 & 2005

Kamera Content Private placement Media January 2006 SRAB Kemtank 1 Private placement Transports September 2006 Annehem Private placement Real estate December 2006 Stille Secondary Med tech January 2006 Micro Holding Rights issue Retail December 2006 LimaForsgrens Secondary Real estate August 2006 Glycorex Directed share issue Med tech May 2006 Annehem Private placement Real estate May 2006 Xover Private placement Media March 2006 Guideline IPO Technology November 2005 Lima Timmerhus Private placement Real estate November 2005 Glycorex Rights issue Med tech October 2005 Sweden Mobile Systems Private placement IT June 2005 MedCap (fmr. New Science) Underwriting Investments May 2005 Tricorona Secondary Resources May 2005 A-com Underwriting Media April 2005

slide-18
SLIDE 18

Stockholm Corporate Finance

CAPITAL MARKET FAIRS

18

Capital Market Fairs

  • Stockholm Corporate Finance has organized in collaboration with

Financial Hearings annual Capital Market Fairs since 2007.

  • The purpose of the Capital Market Fairs is to offer investors, the media

and analysts a time-efficient way to engage with interesting companies, and potentially arrange individual meetings with company executives.

  • Veckans Affärer are ordinarily leading the Q&A session. In addition to the

presenting companies,

Represented companies Key Note Speakers

Per Agerman Leif Andersson Magdalena Andersson Rutger Arnhult Lars Backsell Susanna Campbell Magnus Ericsson Per-Olof Eriksson Harry Flam Mattias Goldmann Helene Hellmark Knutsson Peter Honeth Sven Olof Johansson Mats Leifland Staffan Lindstrand Patric Lindqvist Peter Norhammar Erik Paulsson Lennart Sten Javier Sanz Editor-in-chief at Realtid.se Founder Areim Minister of Finance (then: Economic Policy Spokesperson) CEO Klövern, Board Member at Klövern, Corem, AGORA Founder of Recip and Recipharm Investor Impact Investing Professor and CEO of Raw Materials Group Ex-CEO Sandvik, Board Member HealthCap Fiscal Policy Council CEO Fores Minister for Higher Education and Research State Secretary at the Department of Education CEO FastPartner CEO Medicon Village Senior Partner HealthCap Fund manager Handelsbanken Fonder Head of Swedish Equities Alfred Berg Entrepreneur, Backahill, Fabege, Peab CEO Svenska Handelsfastigheter CTO Renewable Energy at InnoEnergy

Annual Capital Market Fairs since 2007

LIFE SCIENCE & MED TECH Accelerator Allenex Arcoma Artimplant Aptahem Asarina Pharma Avonova Bacticguard BioGaia BioInvent Biolin Scientific BioPhausia BioArctic bioServo Bluefish BoneSupport Boule Diagnostics Brighter C-Rad Calliditas Calmark Camurus Cellavision Combigene Creative Antibiotics Diamyd Medical Dignitana Doxa Ellen AB Enzymatica AB Episurf Follicum Genovis GHP Speciality Care Glycorex Hansa Medical InDex Pharmaceuticals IRRAS IRLAB Isconova Isofol Medical Izafe Kancera KaroBio Karolinska Development MedCap Medicon Village Medivir Midsona Moberg Pharma Neurovive NextCell Pharma Oasmia Pharmaceutical Oncopeptides OraSolv Orexo Pledpharma Probi Scibase Sedana Medical Stille Recipharm Redwood Pharma Vibrosense Dynamics Vicore Pharma Vitrolife WntResearch Q-Linea QuiaPEG Pharmaceuticals Zealand Pharma Xvivo Perfusion REAL ESTATE Acrinova A Group of Retail Assets Amasten Holding Atrium Ljungberg Brinova Catena Fastigheter Concent Holding Corem Property Group D.Carnegie Fabege Fastator INDUSTRIAL Axlon Consilium Duroc Precomp Sol. Railcare IT Fortnox Invisio Paynova Seanet Smarteq CLEANTEC Alelion Cell Impact Climeon Ecoclime Eolus Vind Fores Impact Coatings Instalco Minesto MyFC Northvolt Rindi Energi Raybased Vätgas Sverige SaltX Technology RETAIL Nordic Service Partners SERVICES NGS Group SHIPPING SRAB Genova Heba Högkullen Index International Klövern Kungsleden Magnolia Bostad MaxFastigheter NP3 Oscar Properties Prime Living Stendörren Fastigheter Svenska Bostadsfonden Tobin Properties Victoria Park RAW MATERIALS Arctic Gold Auriant Mining Beowulf mining Botnia Exploration Cassandra Oil Central Asia Gold Dannemora Mineral Delta Minerals Dome Energy Drillcon Endomines Gripen Oil & Gas Interfox Resources Maha Energy Metallvärden Kopylovskoye Kopparberg Mineral Lappland Goldminers Lundin Petrolium Nordic Iron Ore Northland Res. Shelton Petr. Sotkamo Silver Tethys oil Tricorona

slide-19
SLIDE 19

Marcus Bonsib +46 8 440 56 40 +46 72 182 72 90 marcus.bonsib@stockholmcorp.se Jan Lundberg +46 8 440 56 40 +46 705 71 41 24 jan.lundberg@stockholmcorp.se Axel Enström +46 8 440 56 40 +46 706 74 72 58 axel.enstrom@stockholmcorp.se Daniel Hofmann +46 (0) 8 440 56 40 +46 (0) 708 86 69 01 daniel.hofmann@stockholmcorp.se Andor Gerendas +46 8 440 56 40 +46 709 99 26 52 andor.gerendas@stockholmcorp.se Daniel Hummel +46 (0) 8 440 56 40 +46 (0) 706 61 24 29 daniel.hummel@stockholmcorp.se Magnus Härning-Nilsson +46 8 440 56 57 +46 709 18 08 03 magnus.harning-nilsson@stockholmcorp.se Ingemar Lagerlöf +46 8 440 56 40 +46 708 73 27 33 ingemar.lagerlof@stockholmcorp.se Markus Lagerlöf +46 8 440 56 40 +46 706 12 02 09 markus.lagerlof@stockholmcorp.se Stockholm Corporate Finance AB Birger Jarlsgatan 32 A, 114 29 Stockholm Visiting adress: Engelbrektsplan 1 Tel +46 8 440 56 40 Fax +46 8 440 56 41 www.stockholmcorp.se Per Thunander +46 8 440 56 55 +46 708 66 43 60 per.thunander@stockholmcorp.se Linda Nottemark + 46 8 440 56 40 +46 735 06 06 94 Linda.nottemark@stockholmcorp.se Otto Rydbeck +46 8 440 56 45 +46 708 78 48 70

  • tto.rydbeck@stockholmcorp.se

Albert Sandwall +46 8 440 56 40 +46 72 500 20 02 albert.sandwall@stockholmcorp.se Harry Nudel +46 8 440 56 52 +46 706 73 73 00 harry.nudel@stockholmcorp.se Gunnar Wedfelt +46 8 440 56 51 +46 733 77 08 78 gunnar.wedfelt@stockholmcorp.se Marcus Rohdin +46 8 440 56 40 +46 706 34 80 66 marcus.rohdin@stockholmcorp.se Martin Wedfelt +46 8 440 56 40 +46 735 25 04 46 martin.wedfelt@stockholmcorp.se Niklas de Mander +46 8 440 56 40 +46 761 77 81 50 niklas.de.mander@stockholmcorp.se